高致病性禽流感分子鉴别诊断方法的建立

为了快速、敏感、特异地鉴别诊断高致病性禽流感,根据H 5,H 7亚型禽流感病毒HA基因序列的保守区域设计出并合成两对特异性引物,利用这两对引物对H 5,H 7亚型禽流感病毒的HA基因片断进行二联RT-PCR扩增,并对二联RT-PCR检测方法进行敏感性及特异性试验。结果表明:这两对引物能特异性地扩增出H 5,H 7亚型禽流感病毒HA基因片段,大小分别为490 bp和375 bp;该检测方法敏感性高,特异性强;初步建立起快速、敏感、特异地鉴别检测H 5,H 7亚型高致病性禽流感病毒的分子诊断方法。     

禽流感病毒H5亚型特异性抗原捕捉ELISA检测方法的研究

 在获得禽流感病毒多克隆抗体及H5亚型特异性单克隆抗体的基础上,研究建立H5亚型特异性抗原捕捉ELISA检测方法,用于检测H5亚型禽流感病毒.优化反应条件,确定包被抗体、检测抗体及酶结合物的最佳工作浓度,进行敏感性、特异性、重复性及稳定性分析,并与RT-PCR方法比较.同时使用该方法对野外样品进行检测.结果表明:该方法敏感、特异,具有良好的重复性和稳定性,可用于检测临床样品、鸡胚培养物及细胞培养物中的H5亚型禽流感病毒.     

山鸡感染禽流感H9亚型病毒的分离鉴定

禽流感H9亚型病毒(AIVH9)为低致病性病毒,毒力相对较弱,若无并发症,死亡率不高,主要出现呼吸道症状。2005年6月某珍禽养殖场饲养珍禽山鸡突然发病,通过发病情况调查、观察临床症状、病理变化,同时采取发病鸡的血液分离血清测定AIH5、AIH9和ND的抗体;采集病鸡内脏接种鸡胚尿囊腔分离到一株病毒,该分离株具有血凝活性,经鉴定为AIVH9亚型,表明禽流感不仅危及家禽,一些珍禽也有自然感染AIV的潜在性。     

禽流感病毒H9亚型特异性抗原捕捉ELISA检测方法的研究

 采用禽流感病毒多克隆抗体及H9亚型特异性单克隆抗体,研究建立H9亚型特异性抗原捕捉ELISA检测方法,用于检测H9亚型禽流感病毒.优化了反应条件,确定了包被抗体、检测抗体及酶结合物的最佳工作浓度,对该方法的敏感性、特异性、重复性及稳定性分析,并与RT-PCR方法比较.通过使用该方法对野外样品进行检测.结果表明该方法敏感、特异,具有良好的重复性和稳定性,可用于检测临床样品、鸡胚培养物及细胞培养物中的H9亚型禽流感病毒.     

H5N1亚型禽流感病毒NS1基因的克隆及原核表达

克隆、表达和纯化禽流感病毒H5N1 NS1基因序列,为筛选与NS1相互作用的宿主蛋白以及深入研究NS1蛋白的功能打下基础.根据GenBank中收录的H5N1亚型禽流感病毒NS1基因序列,设计并合成一对特异性引物,利用RT-PCR方法扩增AIV NS1基因,将酶切处理后的基因片段定向克隆到原核表达载体pET-28a载体上,经酶切分析及序列测定正确后,鉴定出NS1基因的阳性重组子.阳性质粒转化大肠杆菌BL21(DE3)感受态细胞,用1 mmol/L IPTG诱导表达,表达产物进行SDS-PAGE检测,获得预期蛋白的表达,通过Ni-NTA树脂蛋白纯化系统对NS1蛋白进行纯化.结果成功克隆H5N1亚型AIV的NSl基因,其核苷酸序列长度为678 bp,重组蛋白在大肠杆菌中可以高效表达,SDS-PAGE显示其相对分子质量与预计大小一致,表达产物在上清及包涵体中均有表达.经纯化,目的蛋白纯度高达90%,成功表达纯化出28KD的NS1融合蛋白并鉴定其免疫学活性.成功克隆和表达了禽流感病毒H5N1 NS1基因序列,为进一步研究NS1蛋白的生物学功能奠定了坚实基础.     

禽流感病毒型及亚型特异性免疫酶染色技术的研究

 在获得禽流感病毒型及亚型特异性单克隆抗体的基础上,研究建立型及亚型特异性免疫酶染色技术,用于检测或鉴定禽流感病毒．优化反应条件,确定单克隆抗体及辣根过氧化物酶标记二抗的最佳工作浓度,进行敏感性、特异性、重复性及稳定性分析,并与病毒分离鉴定比较．结果表明该方法敏感、特异,具有良好的重复性和稳定性,可用于检测临床组织样品、鸡胚及细胞培养物中的禽流感病毒．     

通过载体表达siRNAs抑制禽流感病毒复制的研究

禽流感病毒是养禽业危害最严重的病原微生物之一。为探讨小干涉RNA(siRNA)对A型禽流感病毒复制的干扰作用,以H5亚型AIV PB2基因为靶序列,设计合成了4对编码siRNAs的DNA序列,将其克隆到psiRNA-hH1neo载体中,构建siRNAs表达载体,鉴定正确后将重组质粒转染MDCK细胞,采用G418筛选建立抗性细胞系,用血凝(HA)试验和real time RT-PCR试验检测抑制效果, 在细胞水平筛选出具有高效抑制AIV复制的2个靶位点PB2-1154、PB2-342、为AIV的基因功能研究,抗病毒药物的开发和转基因动物的研究奠定了基础。     

一株Ⅱ型草鱼呼肠孤病毒强毒株的分离鉴定及全基因组序列分析

目的 对一例典型草鱼出血病的病原进行分离、鉴定和全基因组序列分析.方法 采用细胞培养分离病毒、PCR检测和测序分析、电镜观察、间接免疫荧光(IFA)分析、全基因组序列测定及回归感染鉴定对采集的草鱼出血病样品进行病原分析.结果 接种病毒的细胞没有产生CPE,但电镜观察可见大量呈典型呼肠孤病毒特点的病毒粒子,PCR检测并测...     

病毒样颗粒为阳性对照的H5N1实时荧光定量PCR检测方法的建立

合适的标准品对实时荧光定量PCR(qPCR)检测高致病性H5N1禽流感病毒(avain influenza virus,AIV)十分重要.本研究将H5N1AIV HA基因的部分序列插入到能够表达MS2噬菌体病毒样颗粒(virus-like particle,VLP)DNA序列的表达载体上,诱导表达后得到了包裹有H5N1AIV HA基因RNA片段的VLP.该VLP能够耐受核酶的消化,形态与MS2噬菌体病毒颗粒形态相同.利用表达的VLP作为阳性标准品及设计的特异性荧光探针、淬灭链,使用优化的qPCR反应体系,得到qPCR检测H5N1亚型AIV的阳性对照标准曲线.研究结果为高致病性H5N1亚型AIV的准确定量检测提供了基础.     

乙型脑炎病毒(JEV)单克隆抗体的制备及初步应用

目的制备乙型脑炎病毒(JEV)单克隆抗体,应用于猪源性生物制品中JEV的检测。方法提纯病毒抗原,免疫BALB/c小鼠,取脾细胞与SP2/0骨髓瘤细胞融合,经间接ELISA方法筛选和有限稀释法三次克隆获得4株杂交瘤细胞,并应用琼脂扩散、酶联免疫吸附试验和免疫荧光方法进行抗体鉴定和样品检测。结果获得4株稳定分泌JEV单克隆抗体的杂交瘤细胞株G10、F4、C10、A5,免疫荧光抗体实验证实是特异的抗JEV抗体,其免疫球蛋白亚类G10和F4为IgG1,A5为IgM,C10未鉴定出其亚类。G10和F4腹水效价为105以上,C10和A5腹水效价为102以上。结论成功制备了抗JEV单克隆抗体,建立了以单抗介导的间接ELISA和间接IFA检测方法,并应用于猪源性生物制品中JEV的检测。     

Prediction of a common neutralizing epitope of H5N1 avian influenza virus by in silico molecular docking

The H5N1 avian influenza virus (AIV) has widely spread in Asia, Europe and Africa, making a large amount of economic loss. Recently, our research group has screened a common neutralizing mono- clonal antibody named 8H5, which can neutralize almost all H5 subtype AIV ever isolated so far. Obvi- ously, this monoclonal antibody would benefit for research and development of the universal AIV vac- cine and design of the drug against H5N1 AIV in high mutation rate. In this study, the homology mod- eling was applied to generate the 3D structure of 8H5 Fab fragment, and "canonical structure" method was used to define the specified loop conformation of CDR regions. The model was subjected to en- ergy minimization in cvff force field with Discovery module in Insight II program. The resulting model has correct stereochemistry as gauged from the Ramachandran plot calculation and good 3D-structure compatibility as assessed by interaction energy analysis, solvent accessible surface (SAS) analysis, and Profiles-3D approach. Furthermore, the 8H5 Fab model was subjected to docking with three H5 subtype hemagglutinin (HA) structures deposited in PDB (ID No: 1jsm, 2ibx and 2fk0) respectively. The result indicates that the three docked complexes share a common binding interface, but differ in bind- ing angle related with HA structure similarity between viral subtypes. In the light of the three HA inter- faces with structural homology analysis, the common neutralizing epitope on HA recognized by 8H5 consists of 9 incontinuous amino acid residues: Asp68, Asn72, Glu112, Lys113, Ile114, Pro118, Ser120, Tyr137, Tyr252 (numbered as for 1jsm sequence). The primary purpose of the present work is to provide some insight into structure and binding details of a common neutralizing epitope of H5N1 AIV, thereby aiding in the structure-based design of universal AIV vaccines and anti-virus therapeutic drugs.     

Prediction of a common neutralizing epitope of H5N1 avian influenza virus by in silico molecular docking

The H5N1 avian influenza virus （AIV） has widely spread in Asia, Europe and Africa, making a large amount of economic loss. Recently, our research group has screened a common neutralizing mono-clonal antibody named 8H5, which can neutralize almost all H5 subtype AIV ever isolated so far. Obviously, this monoclonal antibody would benefit for research and development of the universal AIV vac-cine and design of the drug against H5N1 AIV in high mutation rate. In this study, the homology modeling was applied to generate the 3D structure of 8H5 Fab fragment, and ＂canonical structure＂ method was used to define the specified loop conformation of CDR regions. The model was subjected to energy minimization in cvff force field with Discovery module in Insight II program. The resulting model has correct stereochemistry as gauged from the Ramachandran plot calculation and good 3D-structure compatibility as assessed by interaction energy analysis, solvent accessible surface （SAS） analysis, and Profiles-3D approach. Furthermore, the 8H5 Fab model was subjected to docking with three H5 subtype hemagglutinin （HA） structures deposited in PDB （ID No： ljsm, 2ibx and 2fk0） respectively. The result indicates that the three docked complexes share a common binding interface, but differ in binding angle related with HA structure similarity between viral subtypes. In the light of the three HA inter-faces with structural homology analysis, the common neutralizing epitope on HA recognized by 8H5 consists of 9 incontinuous amino acid residues： Asp^58, Asn^72, Glu^112, Lys^113, lie^114, Pro^118, Ser^120, Tyr^137, Tyr^252 （numbered as for ljsm sequence）. The primary purpose of the present work is to provide some insight into structure and binding details of a common neutralizing epitope of H5N1 AIV, thereby aiding in the structure-based design of universal AIV vaccines and anti-virus therapeutic drugs.     

Epidemiological and risk analysis of the H7N9 subtype influenza outbreak in China at its early stage

Dozens of human cases infected with H7N9 subtype avian influenza virus (AIV) have been confirmed in China since March, 2013. Distribution data of sexes, ages, professions and regions of the cases were analyzed in this report. The results showed that the elderly cases, especially the male elderly, were significantly more than expected, which is different from human cases of H5N1 avian influenza and human cases of the pandemic H1N1 influenza. The outbreak was rated as a Grade Ⅲ (severe) outbreak, and it would evolve into a Grade IV (very severe) outbreak soon, using a method reported previously. The H7N9 AIV will probably circulate in humans, birds and pigs for years. Moreover, with the driving force of natural selection, the virus will probably evolve into highly pathogenic AIV in birds, and into a deadly pandemic influenza virus in humans. Therefore, the H7N9 outbreak has been assumed severe, and it is likely to become very or extremely severe in the future, highlighting the emergent need of forceful scientific measures to eliminate any infected animal flocks. We also described two possible mild scenarios of the future evolution of the outbreak.     

Immunogenicity of recombinant fowl-pox virus co-expressing structural protein precursor P1-2A and proteinase 3C of FMDV

Two recombinant plasmids, pUTA2P1 and pUTAL3CP1, were constructed by inserting structural protein precursor P1-2A and proteinase 3C of foot-and-mouth disease virus (FMDV) into fowl-pox virus (FPV) recombinant vectors pUTA-2 and pUTA-16-LacZ respectively, and two recombinant FPVs (vUTA2P1 and vUTAL3CP1) screened by the RT-PCR, IFA assay and Western blotting assay were obtained successfully. Mice injected respectively with rFPVs were induced high level specific anti-FMDV antibodies, increasing of T subtypes, and higher cytotoxicities of splenocytes than those of control groups. These results indicated that a new method was used to construct a potential candidate vaccine of FMDV.     

H5N1亚型禽流感病毒血凝素基因的克隆与表达

 根据已知H5N1亚型禽流感病毒血凝素(HA)基因序列设计、合成克隆引物.自灭活的云南地方H5N1亚型病毒阳性临床组织样品中提取总RNA,反转录后采用高可信度DNA聚合酶(Pyobest^TMDNA Polymerase)扩增HA基因,采用Invitrogen定向表达系统(Champion^TMpET directional TOPO expression system)进行克隆表达,纯化获得N末端携带多聚组氨酸标签的重组HA,分子质量约78ku.采用阳性血清经免疫印迹及ELISA分析重组HA的免疫反应性,结果表明重组HA能与H5N1亚型病毒抗血清发生特异性结合,具有良好的免疫反应性.     

运用链特异性RT-PCR法进行脊髓灰质炎灭活疫苗的灭活验证

运用链特异性逆转录聚合酶链式反应法(RT-PCR)建立了一种快速、灵敏、特异的脊髓灰质炎灭活疫苗(IPV)的灭活验证体系.以Sabin株脊髓灰质炎病毒悬液作为阳性对照,对脊髓灰质炎灭活疫苗进行检测.结果表明,链特异性RT-PCR法对具有活性的脊髓灰质炎病毒检测为阳性,而对脊髓灰质炎灭活疫苗的检测结果为阴性.链特异性RT-PCR法可作为一种简便、快速、灵敏的脊髓灰质炎灭活疫苗灭活验证方法,大大缩短了检测周期,在脊髓灰质炎灭活疫苗灭活验证的常规检测中具有较好的实际应用价值.     

Subtyping of type A influenza by sequencing the variable regions of HA gene specifically amplified with RT-PCR

The outbreak of a novel influenza A （H1N1） virus across the globe poses a threat to human health. It is of paramount importance to develop a rapid, reliable and inexpensive diagnostic procedure. Based on the bioinformatic information from public database, primers specific for influenza A virus surface protein haemagglutinin （HA） of several subtypes （including H1, H2, H3, H5, H7 and H9） were designed. Primer-specific PCR products were subiected to sequencing for accurately distinguishing H1 and H3 subtypes from others. This sequencing-based detection method will not only be applied to rapid detection and simultaneous subtype identification of new influenza A virus H1N1, but also provide the strategies to monitor other new types of influenza virus with explosive potential.